Relative importance of cardioselectivity and partial agonism in the treatment of hypertension in the patient with air-flow obstruction.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000402:Airway Obstruction / Q000150:complications*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D009928:Organ Specificity; D010096:Oxprenolol / Q000627:therapeutic use; D010869:Pindolol / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012119:Respiration / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D011433:Propranolol; D010869:Pindolol; D011217:Practolol